Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evolution of blood pressure control in Spain.

Literature DB >> 17762665

Evolution of blood pressure control in Spain.

Vivencio Barrios, José R Banegas, Luis M Ruilope, José L Rodicio.

Abstract

Mesh：

Year: 2007 PMID： 17762665 DOI： 10.1097/HJH.0b013e32829fb3ec

Source DB: PubMed Journal: J Hypertens ISSN： 0263-6352 Impact factor: 4.844

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study).

Authors: Manel Pladevall; Carlos Brotons; Rafael Gabriel; Anna Arnau; Carmen Suarez; Mariano de la Figuera; Emilio Marquez; Antonio Coca; Javier Sobrino; George Divine; Michele Heisler; L Keoki Williams
Journal: Circulation Date: 2010-09-07 Impact factor: 29.690

2. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Authors: Vivencio Barrios; Peter Brommer; Uwe Haag; Alberto Calderón; Carlos Escobar
Journal: Clin Drug Investig Date: 2009 Impact factor: 2.859

3. [Assessment of electronic medical records. Relationship between process indicators measured using electronic records and intermediate health outcomes in patients with hypertension].

Authors: Gerardo Garzón González; David Rodríguez Morales; Miguel Ángel Rodríguez Palomino; David Toledo Gómez; Valentín Hernández Barrera; Angel Gil De Miguel
Journal: Aten Primaria Date: 2012-09-13 Impact factor: 1.137

4. When the clinical trials raise more questions than answers: blood pressure controversy beyond the TRANSCEND results.

Authors: Vivencio Barrios; Carlos Escobar; Rocio Echarri; Alberto Calderon
Journal: J Clin Hypertens (Greenwich) Date: 2009-03 Impact factor: 3.738

5. Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study.

Authors: Beatriz De Rivas; Vivencio Barrios; Josep Redón; Alberto Calderón
Journal: J Clin Hypertens (Greenwich) Date: 2010-05 Impact factor: 3.738

6. Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility.

Authors: Vivencio Barrios; Carlos Escobar
Journal: Integr Blood Press Control Date: 2010-05-10

Evolution of blood pressure control in Spain.

1. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study).

2. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

3. [Assessment of electronic medical records. Relationship between process indicators measured using electronic records and intermediate health outcomes in patients with hypertension].

4. When the clinical trials raise more questions than answers: blood pressure controversy beyond the TRANSCEND results.

5. Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study.

6. Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility.

7. Emerging drug combinations to optimize renovascular protection and blood pressure goals.

8. Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.

9. Sex differences in the hypertensive population with chronic ischemic heart disease.

Review 10. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.